85 related articles for article (PubMed ID: 657132)
1. Multisystem stem cell failure after apparent recovery from alkylating agents.
Botnick LE; Hannon EC; Hellman S
Cancer Res; 1978 Jul; 38(7):1942-7. PubMed ID: 657132
[No Abstract] [Full Text] [Related]
2. A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents.
Botnick LE; Hannon EC; Hellman S
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1621-5. PubMed ID: 395140
[No Abstract] [Full Text] [Related]
3. Late effects of chemotherapy on hematopoietic progenitor cells.
Fried W; Adler S
Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
[TBL] [Abstract][Full Text] [Related]
6. [The role of SC-1(+)- and Thy-1(+)-cells in the regulation of cytokine production by cells of the bone marrow regenerating after cytostatic action].
Dygaĭ AM; Sherstoboev EIu; Gol'dberg ED
Biull Eksp Biol Med; 1998 Apr; 125(4):374-7. PubMed ID: 9631712
[No Abstract] [Full Text] [Related]
7. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
Basch RS; Quito FL; Beh J; Hirst JA
Stem Cells; 1997; 15(4):314-23. PubMed ID: 9253116
[TBL] [Abstract][Full Text] [Related]
8. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Valeriote FA; Tolen SJ
Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
[No Abstract] [Full Text] [Related]
9. The problem of permanent bone marrow damage after cytotoxic drug treatment.
Lohrmann HP
Oncology; 1984; 41(3):180-4. PubMed ID: 6374556
[TBL] [Abstract][Full Text] [Related]
10. [The mechanisms of the disordered regulation of hematopoiesis in the late periods after the administration of cytostatic preparations].
Novitskiĭ VV; Zapuskalova OB; Bogdashin IV; Gol'dberg ED
Patol Fiziol Eksp Ter; 1991; (3):12-4. PubMed ID: 1923603
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
12. Limited proliferation of stem cells surviving alkylating agents.
Botnick LE; Hannon EC; Hellman S
Nature; 1976 Jul; 262(5563):68-70. PubMed ID: 934328
[No Abstract] [Full Text] [Related]
13. Tumor inductions by cytostatics in man.
Hunstein W
Recent Results Cancer Res; 1975; (52):50-6. PubMed ID: 796914
[No Abstract] [Full Text] [Related]
14. [The role of proliferation and differentiation of the hematopoietic cell precursors during regeneration of hematopoiesis in cytostatic myelosuppression].
Dygaĭ AM; Zhdanov VV; Minakova MIu; Ryzhakov VM; Gol'dberg ED
Biull Eksp Biol Med; 1997 Dec; 124(12):616-20. PubMed ID: 9483310
[No Abstract] [Full Text] [Related]
15. Limitations of oral busulfan in preparative regimen before hematopoietic stem-cell transplantation.
Kami M; Hamaki T; Maruta Y; Miyakoshi S; Mutou Y
Haematologica; 2002 Feb; 87(2):ELT10. PubMed ID: 11836187
[No Abstract] [Full Text] [Related]
16. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
17. The effects of leukemia and lymphoma chemotherapy on hematopoietic cells.
Brunning RD
Am J Med Technol; 1973 May; 39(5):165-74. PubMed ID: 4701364
[No Abstract] [Full Text] [Related]
18. [Comparative characteristics of CFU-C from different hematopoietic tissues].
Starostin VI; Sokolova EA; Khrushchov NG
Dokl Akad Nauk SSSR; 1985; 284(3):735-9. PubMed ID: 2865095
[No Abstract] [Full Text] [Related]
19. [The effect of antineoplastic alkylating agents on the serum protein fraction of rats with sarcoma 45].
Kulik GI; Pel'kis FP
Vopr Onkol; 1969; 15(7):68-71. PubMed ID: 4980425
[No Abstract] [Full Text] [Related]
20. [B-lymphocytes and the proliferative response of a hemopoietic stem cell to antigenic action].
Kozlov VA; Tsyrlova IG; Gaĭdul' KV
Dokl Akad Nauk SSSR; 1986; 286(1):239-41. PubMed ID: 3485040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
